Maintaining Blood Glucose Levels in Range (70-150 mg/dL) is Difficult in COVID-19 Compared to Non-COVID-19 ICU Patients-A Retrospective Analysis.
Maintaining Blood Glucose Levels in Range (70-150 mg/dL) is Difficult in COVID-19 Compared to Non-COVID-19 ICU Patients-A Retrospective Analysis.
复制标题
DOI:
10.3390/jcm9113635
复制
发表时间:
2020-11-12
影响因子:
3.9
通讯作者:
Rahman O
中科院分区:
文献类型:
--
作者:
Kapoor R;Timsina LR;Gupta N;Kaur H;Vidger AJ;Pollander AM;Jacobi J;Khare S;Rahman O
Beta cell dysfunction is suggested in patients with COVID-19 infections. Poor glycemic control in ICU is associated with poor patient outcomes. This is a single center, retrospective analysis of 562 patients in an intensive care unit from 1 March to 30 April 2020. We review the time in range (70–150 mg/dL) spent by critically ill COVID-19 patients and non-COVID-19 patients, along with the daily insulin use. Ninety-three in the COVID-19 cohort and 469 in the non-COVID-19 cohort were compared for percentage of blood glucose TIR (70–150 mg/dL) and average daily insulin use. The COVID-19 cohort spent significantly less TIR (70–150 mg/dL) compared to the non-COVID-19 cohort (44.4% vs. 68.5%). Daily average insulin use in the COVID-19 cohort was higher (8.37 units versus 6.17 units). ICU COVID-19 patients spent less time in range (70–150 mg/dL) and required higher daily insulin dose. A higher requirement for ventilator and days on ventilator was associated with a lower TIR. Mortality was lower for COVID-19 patients who achieved a higher TIR.
登录
查看更多内容
影响因子:
82.9
作者:
Kuba K;Imai Y;Rao S;Gao H;Guo F;Guan B;Huan Y;Yang P;Zhang Y;Deng W;Bao L;Zhang B;Liu G;Wang Z;Chappell M;Liu Y;Zheng D;Leibbrandt A;Wada T;Slutsky AS;Liu D;Qin C;Jiang C;Penninger JM
通讯作者:
Penninger JM
影响因子:
7.3
作者:
Hamming, I;Timens, W;van Goor, H
通讯作者:
van Goor, H
影响因子:
8.9
作者:
Krinsley, JS
通讯作者:
Krinsley, JS
影响因子:
38.9
作者:
Philips, BJ;Meguer, JX;Baker, EH
通讯作者:
Baker, EH
影响因子:
5.8
作者:
Hrebícek, J;Janout, V;Cízek, L
通讯作者:
Cízek, L